Zheng Quan Shi Bao·2025-07-03 09:19Market Overview - A-shares experienced a broad rally on July 3, with the ChiNext Index rising nearly 2%, while Hong Kong stocks faced downward pressure, with the Hang Seng Index and Hang Seng Tech Index both dropping over 1% [1] - The Shanghai Composite Index closed up 0.18% at 3461.15 points, the Shenzhen Component Index rose 1.17% to 10534.58 points, and the ChiNext Index increased by 1.9% to 2164.09 points [1] - The total trading volume in the Shanghai and Shenzhen markets was 13.336 billion yuan, a decrease of over 700 million yuan from the previous day [1] Innovative Drug Sector - The innovative drug concept saw a resurgence, with stocks like Guangsheng Tang and Shenzhou Cell hitting the 20% limit up, and other companies like Shanghai Yizhong and Hotview Bio rising over 10% [2][4] - The National Healthcare Security Administration and the National Health Commission released measures to support the high-quality development of innovative drugs, focusing on R&D support, insurance directory, clinical application, multi-payment, and guarantee measures [2][4] - The policy aims to enhance the efficiency of innovative drug R&D, accelerate market entry, and improve clinical usage capabilities [4] PCB and Computing Industry - Stocks in the PCB and composite copper foil sectors surged, with Yihua New Materials and Zhongyi Technology both hitting the 20% limit up, and Tongguan Copper Foil rising nearly 14% [5] - The demand for domestic computing continues to improve, with leading companies in optical modules and switches expected to perform well due to the surge in AI demand in North America [5] Consumer Electronics Sector - The consumer electronics sector saw significant gains, with Lens Technology rising over 11% and Industrial Fulian hitting the limit up [6] - Companies like Dongshan Precision and Luxshare Precision also experienced notable increases, with Dongshan Precision rising over 9% and Luxshare Precision up over 5% [6] Trade Policy Impact - The announcement of new tariffs by the U.S. on imports from Vietnam may lead to some orders returning to China, benefiting Chinese OEMs with established supply chains [8] - Companies like Luxshare Precision and GoerTek have achieved 60% local procurement in their Vietnamese factories, allowing them to mitigate some tariff risks through supply chain adjustments [8]